FI40096C - Förfaringssätt för framställning av farmakologiskt, t.ex. diuretiskt aktiva 3,8-diazabicyklo-£3,2,1|-oktaner - Google Patents

Förfaringssätt för framställning av farmakologiskt, t.ex. diuretiskt aktiva 3,8-diazabicyklo-£3,2,1|-oktaner

Info

Publication number
FI40096C
FI40096C FI122162A FI122162A FI40096C FI 40096 C FI40096 C FI 40096C FI 122162 A FI122162 A FI 122162A FI 122162 A FI122162 A FI 122162A FI 40096 C FI40096 C FI 40096C
Authority
FI
Finland
Prior art keywords
pharmacologiskt
förfaringssätt
diazabicyclo
octane
för framställning
Prior art date
Application number
FI122162A
Other languages
English (en)
Finnish (fi)
Other versions
FI40096B (fr
Inventor
Cignarella Giorgio
Testa Emilio
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of FI40096B publication Critical patent/FI40096B/fi
Application granted granted Critical
Publication of FI40096C publication Critical patent/FI40096C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/5545Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having eight-membered rings not containing additional condensed or non-condensed nitrogen-containing 3-7 membered rings
FI122162A 1961-06-26 1962-06-25 Förfaringssätt för framställning av farmakologiskt, t.ex. diuretiskt aktiva 3,8-diazabicyklo-£3,2,1|-oktaner FI40096C (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB23076/61A GB949088A (en) 1961-06-26 1961-06-26 Diazabicyclo-octane derivatives

Publications (2)

Publication Number Publication Date
FI40096B FI40096B (fr) 1968-06-28
FI40096C true FI40096C (fi) 1968-10-10

Family

ID=10189738

Family Applications (1)

Application Number Title Priority Date Filing Date
FI122162A FI40096C (fi) 1961-06-26 1962-06-25 Förfaringssätt för framställning av farmakologiskt, t.ex. diuretiskt aktiva 3,8-diazabicyklo-£3,2,1|-oktaner

Country Status (6)

Country Link
BE (1) BE618813A (fr)
BR (1) BR6240334D0 (fr)
CH (1) CH423799A (fr)
DK (1) DK105414C (fr)
FI (1) FI40096C (fr)
GB (1) GB949088A (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1274018B (it) * 1994-02-23 1997-07-14 Riace Ets Derivati del 3,8-diazabiciclo(3.2.1.)ottano ad attivita' analgesica
SE0003795D0 (sv) 2000-10-20 2000-10-20 Astrazeneca Ab Pharmaceutically useful compounds
EP1819709B1 (fr) * 2004-11-30 2009-02-11 Neurosearch A/S Nouveaux derives aryliques diazabicycliques utilises en tant que ligands cholinergiques
US8673920B2 (en) * 2009-05-06 2014-03-18 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2012058116A1 (fr) 2010-10-27 2012-05-03 Merck Sharp & Dohme Corp. Inhibiteurs du canal potassique de la médullaire externe rénale
US9056859B2 (en) 2010-10-29 2015-06-16 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
BR112014003801A2 (pt) 2011-08-19 2017-03-07 Merck Sharp & Dohme composto, composição farmacêutica, e, métodos para a inibição de romk, para a provocação de diurese, natriurese ou ambas, e para o tratamento ou a profilaxia de um ou mais distúrbios
WO2013039802A1 (fr) 2011-09-16 2013-03-21 Merck Sharp & Dohme Corp. Inhibiteurs du canal à potassium de la medulla externe du rein
WO2013062892A1 (fr) 2011-10-25 2013-05-02 Merck Sharp & Dohme Corp. Inhibiteurs du canal potassique médullaire extérieur rénal
WO2013062900A1 (fr) 2011-10-25 2013-05-02 Merck Sharp & Dohme Corp. Inhibiteurs du canal potassique médullaire externe rénal
WO2013066717A1 (fr) 2011-10-31 2013-05-10 Merck Sharp & Dohme Corp. Inhibiteurs du canal potassique médullaire externe rénal
EP2773199B1 (fr) 2011-10-31 2019-04-10 Merck Sharp & Dohme Corp. Inhibiteurs du canal potassique médullaire externe rénal
EP2773351B1 (fr) 2011-10-31 2017-08-23 Merck Sharp & Dohme Corp. Inhibiteurs du canal potassique médullaire externe rénal
WO2013090271A1 (fr) 2011-12-16 2013-06-20 Merck Sharp & Dohme Corp. Inhibiteurs du canal à potassium de la medulla externe du rein
AR092031A1 (es) 2012-07-26 2015-03-18 Merck Sharp & Dohme Inhibidores del canal de potasio medular externo renal
EP2925322B1 (fr) 2012-11-29 2018-10-24 Merck Sharp & Dohme Corp. Inhibiteurs du canal potassique médullaire extérieur rénal
EP2934533B1 (fr) 2012-12-19 2017-11-15 Merck Sharp & Dohme Corp. Inhibiteurs du canal potassique médullaire externe rénal
EP2956142B1 (fr) 2013-02-18 2017-09-20 Merck Sharp & Dohme Corp. Inhibiteurs du canal potassique médullaire extérieur rénal
WO2014150132A1 (fr) 2013-03-15 2014-09-25 Merck Sharp & Dohme Corp. Inhibiteurs du canal potassique médullaire extérieur rénal
EP3027625B1 (fr) 2013-07-31 2018-05-30 Merck Sharp & Dohme Corp. Derives spiro-fusionnes de piperidine utiles dans le traitement, entre autres, de l'hypertension et de l' insuffisance cardiaque aiguë ou chronique
WO2016127358A1 (fr) 2015-02-12 2016-08-18 Merck Sharp & Dohme Corp. Inhibiteurs du canal potassique médullaire externe rénal

Also Published As

Publication number Publication date
FI40096B (fr) 1968-06-28
CH423799A (de) 1966-11-15
DK105414C (da) 1966-09-26
BE618813A (fr) 1962-10-01
GB949088A (en) 1964-02-12
BR6240334D0 (pt) 1973-05-24

Similar Documents

Publication Publication Date Title
FI40096C (fi) Förfaringssätt för framställning av farmakologiskt, t.ex. diuretiskt aktiva 3,8-diazabicyklo-£3,2,1|-oktaner
BE612258A (fr) 3-X-oxo-1,8-naphtyridines et leur préparation.
FR2165M (fr) 5-(diazacycloalkyl)-10,11-dihydrodibenzocycloheptenes.
FI37834A (fi) Anordning för framställning av tunnväggiga, på en sida öppna kärl, t.ex. bägare av i värme formbart konstämne
BE608766A (fr) Transporteurs.
DK108774C (da) Bortstuvelig mellemdækskonstruktion.
NL143394B (nl) Communicatiestelsel.
FR2259M (fr) Nouveaux médicaments diurétiques.
FR1509M (fr) Nouveau diurétique.
CA615440A (en) Benzothiadiazine-1,1-dioxides
FR1286314A (fr) Moissonneuse, notamment moissonneuse-batteuse
FI40560C (fi) Förfarande för framställning av akrylfibrer
FI35508A (fi) Sätt för framställning av järnpreparat, som intages oralt
CA612932A (en) 9-halo-.delta.4-pregnene-11-oxygenated-16,17-diol-3,20-diones
FI35608A (fi) Förbindelseprofil, särskilt för fönster- och dörramar
FI34339A (fi) Ytterdäck, särskilt för flygmaskiner
AU262959B2 (en) Double-baked, self-channelling electrode
CA620543A (en) 2-methyl-6-fluoro-1,4-pregnadienes
FR2605M (fr) 6,16-diméthyl-15-déhydro-stéroides.
CA631321A (en) 3-oxygenated allopregnane-6,11-dione compounds
CA633032A (en) 2,2-DIARYL-.omega.-(4'-PHENYL-1'-PIPERIDINO) ALKANONITRILES
GR22079B (el) Νεος τυπος καθισματος.
CA622324A (en) 11-OXYGENATED-6-METHYL-9.alpha.,21-DIFLUORO-17.alpha.-HYDROXY-4-PREGNENE-3,20-DIONES
CA622322A (en) 11-OXYGENATED-6-METHYL-17.alpha.-HYDROXY-21-FLUORO-4-PREGNENE-3,20-DIONES
CA622326A (en) 6-METHYL-9.alpha.-FLUORO-11-OXYGENATED-17.alpha.-HYDROXY-4-PREGNENE-3,20-DIONES